Quoin pharmaceuticals appoints gordon dunn as chief financial officer

Ashburn, va., nov. 04, 2021 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has appointed gordon dunn as quoin's chief financial officer, effective immediately.
QNRX Ratings Summary
QNRX Quant Ranking